236 related articles for article (PubMed ID: 11434619)
1. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders.
Realdon S; Pontisso P; Adami F; Trentin L; Noventa F; Ferrari A; Migliorato I; Gatta A; Alberti A
J Hepatol; 2001 May; 34(5):723-9. PubMed ID: 11434619
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hepatitis C virus infection in lymphoproliferative diseases other than B-cell non-Hodgkin's lymphoma, and in myeloproliferative diseases: an Italian Multi-Center case-control study.
Bianco E; Marcucci F; Mele A; Musto P; Cotichini R; Sanpaolo MG; Iannitto E; De Renzo A; Martino B; Specchia G; Montanaro M; Barbui AM; Nieddu R; Pagano L; Rapicetta M; Franceschi S; Mandelli F; Pulsoni A;
Haematologica; 2004 Jan; 89(1):70-6. PubMed ID: 14754608
[TBL] [Abstract][Full Text] [Related]
3. Hepatitis C virus infection in subsets of neoplastic lymphoproliferations not associated with cryoglobulinemia.
Luppi M; Grazia Ferrari M; Bonaccorsi G; Longo G; Narni F; Barozzi P; Marasca R; Mussini C; Torelli G
Leukemia; 1996 Feb; 10(2):351-5. PubMed ID: 8637247
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role.
Zignego AL; Ferri C; Giannini C; La Civita L; Careccia G; Longombardo G; Bellesi G; Caracciolo F; Thiers V; Gentilini P
Arch Virol; 1997; 142(3):545-55. PubMed ID: 9349300
[TBL] [Abstract][Full Text] [Related]
5. Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders.
Libra M; Mangano K; Anzaldi M; Quattrocchi C; Donia M; di Marco R; Signorelli S; Scalia G; Zignego AL; de Re V; Mazzarino MC; Nicoletti F
Oncol Rep; 2006 May; 15(5):1305-8. PubMed ID: 16596202
[TBL] [Abstract][Full Text] [Related]
6. Induction of interleukin-6 by hepatitis C virus core protein in hepatitis C-associated mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma.
Feldmann G; Nischalke HD; Nattermann J; Banas B; Berg T; Teschendorf C; Schmiegel W; Dührsen U; Halangk J; Iwan A; Sauerbruch T; Caselmann WH; Spengler U
Clin Cancer Res; 2006 Aug; 12(15):4491-8. PubMed ID: 16899594
[TBL] [Abstract][Full Text] [Related]
7. Lymphoproliferative diseases and hepatitis C virus infection.
Hausfater P; Rosenthal E; Cacoub P
Ann Med Interne (Paris); 2000 Feb; 151(1):53-7. PubMed ID: 10761563
[TBL] [Abstract][Full Text] [Related]
8. Transfusion-associated TT virus co-infection in patients with hepatitis C virus is associated with type II mixed cryoglobulinemia but not with B-cell non-Hodgkin lymphoma.
Cacoub P; Rosenthal E; Gerolami V; Hausfater P; Ghillani P; Sterkers Y; Thibault V; Khiri H; Piette JC; Halfon P
Clin Microbiol Infect; 2003 Jan; 9(1):39-44. PubMed ID: 12691541
[TBL] [Abstract][Full Text] [Related]
9. Risk of non-Hodgkin lymphoma and lymphoproliferative precursor diseases in US veterans with hepatitis C virus.
Giordano TP; Henderson L; Landgren O; Chiao EY; Kramer JR; El-Serag H; Engels EA
JAMA; 2007 May; 297(18):2010-7. PubMed ID: 17488966
[TBL] [Abstract][Full Text] [Related]
10. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection.
Cacoub P; Bourlière M; Hausfater P; Charlotte F; Khiri H; Toci S; Piette JC; Poynard T; Halfon P
J Viral Hepat; 2003 Jan; 10(1):10-5. PubMed ID: 12558906
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis C virus infection in non-Hodgkin's lymphoma.
King PD; Wilkes JD; Diaz-Arias AA
Clin Lab Haematol; 1998 Apr; 20(2):107-10. PubMed ID: 9681221
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas.
Silvestri F; Barillari G; Fanin R; Pipan C; Falasca E; Salmaso F; Zaja F; Infanti L; Patriarca F; Botta GA; Baccarani M
Haematologica; 1997; 82(3):314-7. PubMed ID: 9234578
[TBL] [Abstract][Full Text] [Related]
13. Elevated Serum Levels of Osteopontin in HCV-Associated Lymphoproliferative Disorders.
Libra M; Indelicato M; De Re V; Zignego AL; Chiocchetti A; Malaponte G; Dianzani U; Nicoletti F; Stivala F; McCubrey JA; Mazzarino MC
Cancer Biol Ther; 2005 Nov; 4(11):1192-4. PubMed ID: 16177564
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia.
Luppi M; Longo G; Ferrari MG; Barozzi P; Marasca R; Morselli M; Valenti C; Mascia T; Vandelli L; Vallisa D; Cavanna L; Torelli G
Ann Oncol; 1998 May; 9(5):495-8. PubMed ID: 9653489
[TBL] [Abstract][Full Text] [Related]
15. HCV-associated lymphomas.
Fiorilli M; Mecucci C; Farci P; Casato M
Rev Clin Exp Hematol; 2003 Dec; 7(4):406-23. PubMed ID: 15129650
[TBL] [Abstract][Full Text] [Related]
16. Serum-free light chain assessment in hepatitis C virus-related lymphoproliferative disorders.
Terrier B; Sène D; Saadoun D; Ghillani-Dalbin P; Thibault V; Delluc A; Piette JC; Cacoub P
Ann Rheum Dis; 2009 Jan; 68(1):89-93. PubMed ID: 18375535
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis C virus risk: a hepatitis C virus related syndrome.
Mazzaro C; Panarello G; Tesio F; Santini G; Crovatto M; Mazzi G; Zorat F; Tulissi P; Pussini E; Baracetti S; Campanacci L; Pozzato G
J Intern Med; 2000 May; 247(5):535-45. PubMed ID: 10809992
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus (HCV) infection and lymphoproliferative disorders.
Libra M; Gasparotto D; Gloghini A; Navolanic PM; De Re V; Carbone A
Front Biosci; 2005 Sep; 10():2460-71. PubMed ID: 15970508
[TBL] [Abstract][Full Text] [Related]
19. [Autoimmune and lymphoproliferative HCV-correlated manifestations: example of mixed cryoglobulinaemia (review)].
Ghinoi A; Mascia MT; Puccini R; Ferri C
G Ital Nefrol; 2004; 21(3):225-37. PubMed ID: 15285001
[TBL] [Abstract][Full Text] [Related]
20. Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma.
Gulli F; Marino M; Napodano C; Pocino K; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8067-8074. PubMed ID: 32767333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
